EUVIMEDEUVIMED entdecken
Crossref

Methotrexate-induced Hyperpigmentation in a Patient with Rheumatoid Arthritis

Samaher Ibrahim Alaauldeen, Hussam Saleh Mayis, Amani Bawazeer, Zuhair Radhwi, Shahad Bamerdah, Waleed A. Hafiz

Annals of Rheumatology and Autoimmunity · 2024

DOI: 10.4103/ara.ara_19_23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Rheumatology and Autoimmunity, 2024. Verfasst von Samaher Ibrahim Alaauldeen und 5 weiteren Autor:innen. Die Arbeit nennt 9 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis (RA) is a chronic progressive systemic and inflammatory disease affecting the lining of the synovial membranes, leading to inflammatory polyarthritis and extraarticular involvement in a symmetrical way. RA is known to be an autoimmune condition, which means that the body’s natural self-defense system gets confused and starts to attack the body’s healthy tissues. Treatment of RA is usually with disease-modifying antirheumatic drugs (DMARDs), but if left untreated, the risk of morbidity, mortality rate, and socioeconomic burdens will increase. Methotrexate (MTX) is one of the folic acid antagonists and one of the conventional synthetic DMARDs. It is the most common drug for the treatment of RA. MTX is a dihydrofolate reductase inhibitor that decreases purine metabolism, which affects cell division. MTX can also cause different types of cutaneous side effects, such as acral erythema, urticaria, ulcerations of the oral mucosa, burning sensation of the skin, multiform erythema, vasculitis, and hyperpigmentation to sun-exposed area. In this case report, we describe a 31-year-old woman who had RA and then developed MTX-induced hyperpigmentation.

Zitieren

APA

Alaauldeen, S. I., Mayis, H. S., Bawazeer, A., Radhwi, Z., Bamerdah, S., & Hafiz, W. A. (2024). Methotrexate-induced Hyperpigmentation in a Patient with Rheumatoid Arthritis. Annals of Rheumatology and Autoimmunity. https://doi.org/10.4103/ara.ara_19_23

Vancouver

Alaauldeen SI, Mayis HS, Bawazeer A, Radhwi Z, Bamerdah S, Hafiz WA. Methotrexate-induced Hyperpigmentation in a Patient with Rheumatoid Arthritis. Annals of Rheumatology and Autoimmunity. 2024. doi:10.4103/ara.ara_19_23

BibTeX
@article{Alaauldeen2024,
  author = {Alaauldeen, Samaher Ibrahim and Mayis, Hussam Saleh and Bawazeer, Amani and Radhwi, Zuhair and Bamerdah, Shahad and Hafiz, Waleed A.},
  title = {Methotrexate-induced Hyperpigmentation in a Patient with Rheumatoid Arthritis},
  journal = {Annals of Rheumatology and Autoimmunity},
  year = {2024},
  doi = {10.4103/ara.ara_19_23}
}
Kostenlos starten →